Active substance: citicoline; 1 ampoule (4 mL) containing citicoline sodium equivalent to 1000 mg of citicoline. Excipients: Water for Injection, phosphoric acid is concentrated.
The solution for injection. 4 mL vials of clear glass type I, 5 vials in a pack.
The acute phase of stroke, complications and consequences of stroke. Traumatic brain injury and its consequences. Neurological disorders (cognitive, sensitive, motor) caused by cerebral degenerative disorders and vascular origin.
For intravenous or intramuscular administration. The recommended dose for adults is 500 mg to 2000 mg per day. In the first 2 weeks appoint 500-1000 mg 2 times a day intravenously, then 500-1000 mg 2 times a day intramuscularly. The maximum daily dose - 2000 mg. In acute conditions maximum therapeutic effect is provided use of the drug product in the first 24 hours. The recommended course of treatment, where there is maximum therapeutic effect of 12 weeks. The dose and duration of treatment depends on the severity of the brain damage and the doctor determined individually. Intravenous administered in the form of slow intravenous injection (for 3-5 minutes, depending on the dose administered) or intravenous drip (40-60 drops per minute). Elderly patients do not require dose adjustment. Children. There is no sufficient data on the drug product to children. The drug product is used in case of emergency, the expected benefits of use exceeds possible risks.